Invesco Ltd. - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 81 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$1,590,000
+668.1%
237,277
+1346.9%
0.00%
Q4 2020$207,000
+58.0%
16,399
+22.7%
0.00%
Q3 2020$131,000
-81.7%
13,362
-81.4%
0.00%
Q2 2020$714,000
+7.5%
71,848
-4.3%
0.00%
Q1 2020$664,000
+328.4%
75,081
+347.7%
0.00%
Q4 2019$155,000
+47.6%
16,771
-6.2%
0.00%
Q3 2019$105,000
-52.9%
17,873
-3.7%
0.00%
Q2 2019$223,000
-23.4%
18,569
-23.0%
0.00%
Q1 2019$291,000
-52.8%
24,110
-42.0%
0.00%
Q3 2018$617,000
-30.9%
41,587
-21.6%
0.00%
Q2 2018$893,000
-75.4%
53,058
-66.5%
0.00%
-100.0%
Q1 2018$3,631,000
+184.8%
158,542
+221.7%
0.00%
Q4 2017$1,275,000
+396.1%
49,287
+183.3%
0.00%
Q3 2017$257,000
-84.5%
17,397
-85.4%
0.00%
-100.0%
Q2 2017$1,662,000
+73.7%
119,184
+112.5%
0.00%
Q1 2017$957,000
+66.4%
56,090
+0.4%
0.00%
Q4 2016$575,000
-27.8%
55,874
-29.1%
0.00%
Q3 2016$796,000
-9.1%
78,845
+1.1%
0.00%
Q2 2016$876,000
-37.2%
77,994
-23.6%
0.00%
-100.0%
Q1 2016$1,395,000
-37.8%
102,140
-13.5%
0.00%0.0%
Q4 2015$2,241,000
+11.2%
118,115
+10.0%
0.00%0.0%
Q3 2015$2,016,000
+40220.0%
107,419
+30158.9%
0.00%
Q2 2015$5,0003550.00%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
BVF INC/IL 2,253,000$7,097,0000.26%
INGALLS & SNYDER LLC 1,358,573$4,280,0000.19%
RA Capital Management 3,033,603$9,556,0000.17%
Kensington Investment Counsel, LLC 85,483$269,0000.16%
Perceptive Advisors 4,301,282$13,548,0000.10%
NewEdge Wealth, LLC 381,326$1,201,0000.05%
Black Diamond Financial, LLC 46,000$145,0000.05%
Birchview Capital, LP 20,000$63,0000.04%
XTX Topco Ltd 14,305$45,0000.02%
Alyeska Investment Group, L.P. 548,090$1,726,0000.02%
View complete list of CONCERT PHARMACEUTICALS INC shareholders